While in some instances NGS may represent an important tool to sustain clinical diagnosis, as is the case represented by the detection of EIF2AK4 biallelic mutations in patients with PAH, in most cases these analyses require detailed biological confirmations, in absence of literature reports. The gene discussed is EIF2AK4; the disease is pulmonary arterial hypertension.